United Kingdom-Derby: Health and social work services – Framework Lead

The current contract for Health and social work services – Framework Lead is projected to end on 20-MAR-21 and may be available for retender. Atypical Haemolytic Uraemic Syndrome Services for NHS England.
Atypical haemolytic uraemic syndrome (aHUS) is a chronic, rare, progressive condition that causes severe inflammation of blood vessels and the formation of blood clots in small blood vessels throughout the body, a process known as systemic thrombotic microangiopathy. NHS England is seeking bids from providers that can deliver a service for patients with aHUS that meets the specific terms set out in the NICE guidance, namely:
– coordination of eculizumab use through an expert centre;
– monitoring systems to record the number of people with a diagnosis of atypical haemolytic uraemic syndrome and the number who have eculizumab, and the dose and duration of treatment;
– a national protocol for starting and stopping eculizumab for clinical reasons; and
– a research programme with robust methods to evaluate when stopping treatment or dose adjustment might occur.
This is intended to be a 3 year contract with the option to extend for a further 2 years.
Common procurement vocabulary (CPV): 85000000,